Mingke Pharmaceutical Industry: Plans to raise approximately 1.03 billion yuan for daily research and development and operational investment at the company.

Meink Pharmaceutical announced that, in order to further enhance the company's overall competitiveness and according to the needs of company development, it plans to issue A-share stocks to specific investors, raising a total amount of no more than 103,257.86 million yuan. After deducting the issuance expenses, the actual raised funds will all be used for the company's daily research and operating investments. After this issuance is completed, the controlling shareholder of the company will change to Haijing Pharmaceutical, and natural person Zhang Xiantao will become the actual controller of the company.